Rchr
J-GLOBAL ID：201801017860598459
Update date: Sep. 17, 2024
NAGAI HIROKAZU
ナガイ ヒロカズ | NAGAI HIROKAZU
Affiliation and department：
Research field (1)：
Hematology and oncology
Research keywords (3)：
climical oncoloty
, malignant lympoma
, hematology
Research theme for competitive and other funds (4)：
- 2011 - 2012 Comparative effectiveness research in first-line therapies for untreated multiple myeloma
- 2010 - 2012 p57KIP2 methylation as a prognostic biomarker of malignant lymphoma
- 2007 - 2008 The analysis of p57KIP2 gene in hematologic malignancies
- 2004 - 2005 Analysis of p57KIP2 gene as tumor suppressor gene
Papers (146)：
-
Shigeru Kusumoto, Wataru Munakata, Ryunosuke Machida, Takashi Terauchi, Hiroaki Onaya, Masahiko Oguchi, Shinsuke Iida, Kisato Nosaka, Yasuhiro Suzuki, Yasuhiko Harada, et al. Interim PET-guided ABVD or ABVD/escalated BEACOPP for newly diagnosed advanced-stage classic Hodgkin lymphoma (JCOG1305). Cancer Science. 2024
-
Motoko Yamaguchi, Noriko Fukuhara, Jun Takizawa, Kenji Ishitsuka, Akihiko Yokohama, Kana Miyazaki, Yuma Nato, Satoshi Ichikawa, Masaki Mitobe, Kodai Shima, et al. Alemtuzumab monotherapy for T-cell prolymphocytic leukemia: an observational study in Japan. Journal of clinical and experimental hematopathology : JCEH. 2024
-
Shinya Rai, Won Seog Kim, Kiyoshi Ando, Ilseung Choi, Koji Izutsu, Norifumi Tsukamoto, Dai Maruyama, Kunihiro Tsukasaki, Junya Kuroda, Jun Ando, et al. Long-term efficacy and safety of tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: final analysis of phase IIb results. Haematologica. 2024
-
Takashi Watanabe, Yoshihiro Matsuno, Masashi Wakabayashi, Dai Maruyama, Kazuhito Yamamoto, Nobuko Kubota, Kazuyuki Shimada, Kohsuke Asagoe, Motoko Yamaguchi, Kiyoshi Ando, et al. Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment: A 15-year follow-up of patients with advanced follicular lymphoma in JCOG0203. Hematological oncology. 2024. 42. 3. e3272
-
Takashi Watanabe, Kensei Tobinai, Masaki Wakabayashi, Dai Maruyama, Kazuhito Yamamoto, Nobuko Kubota, Kazuyuki Shimada, Kohsuke Asagoe, Motoko Yamaguchi, Kiyoshi Ando, et al. R-CHOP treatment for patients with advanced follicular lymphoma: Over 15-year follow-up of JCOG0203. British Journal of Haematology. 2023
ｍore...
MISC (46)：
-
Shinichi Makita, Shigeru Kusumoto, Jun-Ichi Tamaru, Hiroya Hashimoto, Akiko Miyagi Maeshima, Toshiki Uchida, Hideki Tsujimura, Eiichi Ohtsuka, Nobuyuki Takayama, Kayoko Murayama, et al. Copy Number Alterations of Chromosome 9p24.1 in Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received ABVD: An Ancillary Analysis of Multi-Center Retrospective Study in Japan (HORIZON study). BLOOD. 2022. 140. 11890-11892
-
Takashi Watanabe, Kensei Tobinai, Masashi Wakabayashi, Dai Maruyama, Kazuhito Yamamoto, Nobuko Kubota, Kazuyuki Shimada, Kohsuke Asagoe, Motoko Yamaguchi, Kiyoshi Ando, et al. Final Analysis of JCOG0203 for Advanced-Stage Indolent B-Cell Lymphoma 15 Years after the End of Enrollment: Pooled Analysis of Arms a and B for Follicular Lymphoma. BLOOD. 2022. 140. 3615-3617
-
川崎 朋範, 宮口 和也, 田島 知明, 地主 龍平, 中野 佑哉, 永井 宏和, 良沢 昭銘. 長いBarrett食道に発生したMixed neuroendocrine-non-neuroendocrine neoplasm(MiNEN)(Mixed neuroendocrine-non-neuroendocrine neoplasm(MiNEN) arising from long-segment Barrett esophagus). 国立病院総合医学会講演抄録集. 2022. 76回. 1786-1786
-
川崎 朋範, 宮口 和也, 田島 知明, 地主 龍平, 中野 佑哉, 永井 宏和, 良沢 昭銘. Mixed neuroendocrine-non-neuroendocrine neoplasm(MiNEN) arising from long-segment Barrett esophagus(タイトル和訳中). 国立病院総合医学会講演抄録集. 2022. 76回. 1786-1786
-
後藤勇也, 中島崚亮, 榊原真由, 棚橋真規夫, 矢田啓二, 飯田浩充, 永井宏和, 岩越朱里, 西村理恵子, 山本涼子. A case of useful pleural effusion analysis by flow cytometry for accurate diagnosis of angioimmunoblastic T-cell lymphoma. 日本検査血液学会雑誌. 2022. 23. 2. 281-288
ｍore...
Education (1)：
- - 現在 Kanazawa University school of medicine
Work history (1)：
- - 現在 National Hospital Organization Nagoya Medical Center Department of Hematology/Oncology Rearch Directror
Return to Previous Page
